Improving techniques to study proteins that bind to cell membranes
UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
['FUNDING_R01'] · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · NIH-11098889
This study is working on better ways to study important proteins that stick to cell membranes, using new techniques to help scientists see and understand how these proteins work in their natural settings.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11098889 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the techniques used to analyze membrane-binding proteins, which are crucial for many biological processes. By combining two advanced spectroscopic methods, circular dichroism (CD) and Raman optical activity (ROA), the study aims to overcome current limitations in sensitivity that hinder the characterization of these proteins. The researchers will develop new plasmon-enhanced techniques to improve the detection and analysis of these proteins in their natural environments, potentially leading to better understanding of their functions and interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions related to membrane-binding protein dysfunction, such as certain metabolic or neurodegenerative disorders.
Not a fit: Patients with conditions unrelated to membrane-binding proteins or those who do not have any protein-related disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding how membrane-binding proteins function, which may inform the development of new therapies for various diseases.
How similar studies have performed: While the combination of CD and ROA has been explored, the specific approach of using plasmon-enhanced techniques for membrane-binding proteins is relatively novel and has not been widely tested.
Where this research is happening
BOSTON, UNITED STATES
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: REINHARD, BJOERN MARKUS — BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
- Study coordinator: REINHARD, BJOERN MARKUS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.